{"id":"W4389465430","doi":"10.1212/wnl.92.15_supplement.p3.2-054","title":"Long-Term Reduction in 48-Week Confirmed Disability Progression After 5 Years of Ocrelizumab Treatment in Patients With Relapsing Multiple Sclerosis (P3.2-054)","year":2019,"lang":"en","type":"article","venue":"Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Multiple sclerosis; Medicine; Term (time); Pediatrics; Oncology; Internal medicine; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002433304,0.0008356212,0.001497147,0.0002591578,0.0003371781,0.0006838066,0.0005253599,0.0009296749,0.001844512],"category_scores_gemma":[0.001495041,0.0002288837,0.001726356,0.0002685999,0.0003528087,0.0007612772,0.000406045,0.002059503,0.0003323957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006072741,"about_ca_system_score_gemma":0.0008340966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001275863,"about_ca_topic_score_gemma":0.003109619,"domain_scores_codex":[0.9993067,0.0002957509,0.00005178947,0.0001067687,0.00007479736,0.0001641583],"domain_scores_gemma":[0.9988877,0.0002222004,0.0003512736,0.00008797598,0.00008760526,0.000363247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8528476,0.01419287,0.02613054,0.0009686223,0.004485252,0.0001704336,0.0001917867,0.001511904,0.00894259,0.0001600656,0.001892156,0.08850615],"study_design_scores_gemma":[0.2412134,0.5507271,0.1943299,0.0001992754,0.004427119,0.0002563754,0.0001246703,0.001952194,0.003235393,0.0003136483,0.00314695,0.00007406588],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950696,0.002750117,0.0001467145,0.0001448704,0.00007586277,0.0002629802,0.0005433102,0.00002547597,0.0009809667],"genre_scores_gemma":[0.9971972,0.0004828791,0.0002439897,0.0002220537,0.0000725679,0.0002775108,0.0007259167,0.000003967837,0.0007739989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002433304,"threshold_uncertainty_score":0.0128687,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01413660887034244,"score_gpt":0.2419650215227647,"score_spread":0.2278284126524223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}